Clinical Trial Update: Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating APD-209 Eye Drops for therapeutic efficacy in Epidemic keratoconjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidemic Keratoconjunctivitis
• Viral Conjunctivitis

Drugs mentioned

• APD-209 Eye Drops (APD-209)

Snippet

Sponsor: Adenovir Pharma AB | Conditions: Viral Conjunctivitis | Phase 2 | Status: COMPLETED